Delpharm Biotech: an authentic immuno assays diagnostics CMO Delpharm Biotech is an authentic diagnostics CMO based in France specialized in immuno diagnostics, IVD and companion tests. Delpharm Biotech is the former Synbiotics plant (Pfizer’s animal health subsidiary, now part of Zoetis) focused in development and manufacturing of rapid diagnostic tests (Lateral flow immuno assays) and ELISA. Current marketing segment focus is veterinary and human diagnostic kit markets. Based on customer’s already developed prototypes, Delpharm Biotech is able to industrialize test from little pilot batches for field and clinical trials to commercial batches.
With more than 25 years’ experience, our team of specialists, in industrial development, quality control, regulation and manufacturing with state of the art equipment and robots is able to allowing you to get the ultimate quality for you market needs. Delpharm Biotech is now part of Delpharm group, French CMO leader in pharmaceuticals. Delpharm group owns 10 plants across Europe, employs 2,500 people, currently generating in revenue EUR 380 million, and belongs to the top-5 CMO in Europe. As a pharmaceutical and diagnostic CMO, Delpharm complies, depending on each manufacturing plant, with the regulation authorities such as European Medicine Agency (EMA), FDA, veterinary products, OSHAS, ANVISA, PMDA, ISO 9001, and ISO 13485. Downloads: Delpharm group Delpharm synthese avril 2015.pdf